India Precision Medicine Market Report and Forecast 2025-2034

The India precision medicine market was valued at USD 2.40 Billion in 2024, driven by increasing adoption of genomics-based diagnostics and rising government support for personalized healthcare initiatives across the region. The market is anticipated to grow at a CAGR of 11.80% during the forecast period of 2025-2034, with the values likely to reach USD 7.32 Billion by 2034. The market benefits from expanding healthcare infrastructure and growing demand for targeted therapies. Advancements in AI-driven analytics and the integration of electronic health records are expected to boost adoption in the forecast period, contributing to improved patient outcomes and enhanced treatment efficacy.

India Precision Medicine Market Overview

Precision medicine is an advanced medical approach that tailors treatment and prevention strategies to individual genetic, environmental, and lifestyle factors. It aims to improve patient outcomes by providing more accurate diagnoses and targeted therapies based on personal variability. The precision medicine market in India is experiencing significant growth due to increasing healthcare digitization, rising chronic disease prevalence, and advancements in genomics and data analytics. Government initiatives and growing investments in biotechnology further support market expansion. The market is poised to grow at a CAGR of 11.80% during the forecast period of 2025-2034, driven by evolving clinical practices and the adoption of personalized healthcare solutions.

India Precision Medicine Market Growth Drivers

Increasing Prevalence of Cancer to Elevate the Market Growth

The rising prevalence of cancer is emerging as a highly significant growth driver in the precision medicine market in India. According to the Indian Council of Medical Research (ICMR), it was estimated that over 1.4 million new cancer cases were diagnosed across India in 2023 alone. This rising cancer burden is driving strong demand for personalized and targeted therapies that enhance treatment efficacy and reduce adverse effects. As a result, the adoption of precision medicine is accelerating across the country, thereby fueling substantial and continuous expansion of the market.

India Precision Medicine Market Trends

Key trends in the market include the increasing adoption of gene therapy and the formation of strategic genomic collaborations.

Rising Adoption of Gene Therapy to Fuel Innovation in the Market

The growing shift toward gene-based, personalized treatment is redefining the precision medicine landscape in India. Reflecting this trend, in February 2025, India’s Union Minister inaugurated the Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu. The facility, leveraging genomic data and AI, aims to deliver individualized therapies. This advancement is set to accelerate the growth and accessibility of precision medicine across India.

Strategic Collaborations Set to Boost India Precision Medicine Market Value

The market is witnessing a trend towards the expansion of genomic diagnostics through strategic partnerships. In April 2025, Vgenomics and Meril Genomics announced a collaboration to enhance access to advanced genomic tools across Indian hospitals and research institutions. This initiative includes non-invasive prenatal testing, targeted sequencing for tuberculosis, and Whole Exome Sequencing for rare diseases. Such developments are expected to significantly accelerate market growth and patient care innovation.

India Precision Medicine Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

• Diagnostics
• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others
• Therapeutics
• Medical Devices
• Drugs Monoclonal Antibodies Inhibitor Drugs Cell & Gene Therapies Antiviral & Anti-Retroviral Drugs Others
• Others

Market Breakup by Application

• Oncology
• Neurology
• Immunology
• Hematology
• Respiratory
• Others

Market Breakup by End User

• Hospitals and Clinics
• Clinical Laboratories
• Research and Academic Institutes
• Homecare Settings
• Others

Market Breakup by Region

• North India
• East and Central India
• West India
• South India

India Precision Medicine Market Share

Segmentation Based on Application to Witness Substantial Growth

Precision medicines have a wide range of applications across various medical fields, including oncology, neurology, immunology, hematology, respiratory diseases, and others. According to the Indian Council of Medical Research (ICMR), India recorded over 14 lakh new cancer cases in 2023, underscoring the urgent need for targeted treatments. This significant cancer burden positions oncology as the leading application segment within the precision medicine market. The increasing adoption of personalized therapies, driven by advances in genetic testing and molecular diagnostics, further supports oncology’s dominance. Although other segments, such as neurology and immunology, are growing steadily, oncology is expected to remain the primary driver of market growth in India.

India Precision Medicine Market Analysis by Region

The precision medicine market report in India covers North India, East and Central India, West India, and South India. Among these, South India is expected to lead due to its robust healthcare infrastructure and progressive medical initiatives. For instance, in April 2025, SunAct Cancer Institute and Smita Memorial Hospital launched a CAR T-Cell Therapy Centre in Kerala, emphasizing precision oncology, pediatric care, and international clinical trials. This development underscores South India's growing role in advancing affordable, cutting-edge cell and gene therapies.

Leading Players in the India Precision Medicine Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Strand Life Sciences

Strand Life Sciences, established in 2000 and headquartered in Bangalore, India, is a life sciences technology company specializing in bioinformatics, diagnostics, and clinical research. In April 2024, it entered a strategic partnership with SOPHiA GENETICS to advance precision medicine. The collaboration aimed to integrate Strand’s bioinformatics platforms and curated variant databases with the SOPHiA DDM Platform to enhance genomic analysis and support data-driven healthcare decisions, particularly benefiting patient outcomes in India.

MapmyGenome

Established in 2012 and headquartered in Hyderabad, MapmyGenome India Ltd, is a key player in the India precision medicine market. The company specializes in personal genomics and preventive health solutions. Its product, Cardiomap, exemplifies its focus on cardiovascular health by assessing genetic predisposition to heart conditions. MapmyGenome integrates genetic insights with lifestyle data to support personalized prevention strategies, advancing precision medicine in India.

Redcliffe Labs

Redcliffe Labs is actively contributing to the India precision medicine market through innovative diagnostic solutions. It was established in 2018 and is headquartered in Noida, India. In May 2025, the company launched Femcliffe, India’s first women-centric diagnostic platform. Femcliffe offers tailored diagnostic packages across all stages of a woman’s life, addressing conditions like PCOS, reproductive disorders, and metabolic diseases, with services available nationwide.

Novartis AG

Headquartered in Basel, Switzerland, and founded in 1996, Novartis AG is actively engaged in the precision medicine market. The company offers extensive educational and digital resources aimed at enhancing biomarker testing and personalized therapies, particularly in oncology and hematology. Through initiatives such as molecular diagnostics in personalized cancer care and essential elements of biomarker testing, Novartis supports healthcare professionals in delivering targeted, individualized treatments aligned with precision medicine principles.

Other key players in the market include MedGenome Labs, CORE Diagnostics, Positive Bioscience, Neuberg Diagnostics, Leucine Rich Bio, Sarepta Therapeutics, Inc., and GSK Plc

Key Questions Answered in the India Precision Medicine Market Report

• What was the India precision medicine market value in 2024?
• What is the India precision medicine market forecast outlook for 2025-2034?
• What are the major factors aiding the India precision medicine market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major India precision medicine market trends?
• Which type is expected to dominate the market segment?
• Which application is projected to lead the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the India precision medicine market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.